课题基金 / 基金详情

INDIVIDUAL VARIABILITY IN DRUG METABOLISM BY CARBON DIOXIDE BREATH TESTS

INDIVIDUAL VARIABILITY IN DRUG METABOLISM BY CARBON DIOXIDE BREATH TESTS
二氧化碳呼气试验显示药物代谢的个体差异
批准号:
3813488
负责人:
D LALKA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D LALKA的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
preliminary testing of the prediction that caffeine, a low extraction ration drug (0.1) should be a more sensitive probe of enzyme inducttion than methacetin, a high extraction ration drug (0.9), when excretion of a metabolite (C02) is measured has been carried out. A single dose of each was administered to 8 healthy volunteers and 9 epilepsy patients treated with phenytoin, carbarazepine and/or phenobarbital. The 13C carbon dioxide in expired breath was measured y isotope ratio mass spectrometry. The percentages of the dose excreted as CO2 in 2 hr. were compared: 3.22% + 0.86 and 5.54% + 1.59 caffeine was excreted by controls and patients, respectively, compared with 28.6% + 5.8 and 40.0% + 4.2 methacetin. The results in the 2 subject groups were significantly different for both probes (p<.05). These data do not support the theoretical prediction that the extraction ratio of a drug has a critical effect upon its usefulness in detection of induction of oxidative metabolism via the carbon dioxide breath test. In addition, preliminary data illustrate the potential usefulness of this test to follow the time course of changes in drug metabolism/liver function of an alcoholic patient when he stops drinking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INDIVIDUAL VARIABILITY IN DRUG METABOLISM BY CARBON DIOXIDE BREATH TESTS